Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aminoglycoside nephrotoxicity.

F Rougier1, D Claude, M Maurin

  • 1UMR CNRS 5558 - ADCAPT, Service Pharmaceutique, Hôpital Antoine Charial, Hospices Civils de Lyon, Francheville, France. florent.rougier@libertysurf.fr

Current Drug Targets. Infectious Disorders
|June 8, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Implementation of a Length Gauge Based on Optical Frequency Domain Reflectometry (OFDR).

Sensors (Basel, Switzerland)·2026
Same author

Newest Methods and Approaches to Enhance the Performance of Optical Frequency-Domain Reflectometers.

Sensors (Basel, Switzerland)·2024
Same author

Correction to: Clinical impact and cost-consequence analysis of ePlex® blood culture identification panels for the rapid diagnosis of bloodstream infections: a single-center randomized controlled trial.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2024
Same author

Clinical impact and cost-consequence analysis of ePlex® blood culture identification panels for the rapid diagnosis of bloodstream infections: a single-center randomized controlled trial.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2024
Same author

An Optical Frequency Domain Reflectometer's (OFDR) Performance Improvement via Empirical Mode Decomposition (EMD) and Frequency Filtration for Smart Sensing.

Sensors (Basel, Switzerland)·2024
Same author

Antibiotic therapy for infectious hemodialysed patients in Bamako: Pharmacokinetic analyses and first improvement suggestions.

Annales pharmaceutiques francaises·2022
Same journal

Discoveries of Tat-TAR interaction inhibitors for HIV-1.

Current drug targets. Infectious disorders·2006
Same journal

Chemosensitizers in drug transport mechanisms involved in protozoan resistance.

Current drug targets. Infectious disorders·2006
Same journal

Neuraminidase inhibitors as antiviral agents.

Current drug targets. Infectious disorders·2006
Same journal

Developments in antiviral drug design, discovery and development in 2004.

Current drug targets. Infectious disorders·2006
Same journal

Identification of inhibitors of bacterial enoyl-acyl carrier protein reductase.

Current drug targets. Infectious disorders·2005
Same journal

The molecular basis for the mode of action of bicyclomycin.

Current drug targets. Infectious disorders·2005
See all related articles

Aminoglycosides (AG) can cause kidney and ear damage. Optimizing dosing schedules and using predictive models may reduce these toxic effects, improving patient safety.

Area of Science:

  • Pharmacology
  • Nephrology
  • Toxicology

Background:

  • Aminoglycosides (AG) are critical antibiotics but pose risks of nephrotoxicity and ototoxicity.
  • Drug accumulation in the kidney, influenced by dosing, is a key factor in toxicity.
  • Current methods to mitigate toxicity have limitations.

Purpose of the Study:

  • To explore strategies for reducing aminoglycoside-induced nephrotoxicity.
  • To evaluate the effectiveness of different modeling approaches for predicting and managing toxicity.
  • To highlight the complementary roles of probabilistic and deterministic models.

Main Methods:

  • Review of existing approaches including molecular modeling, protective co-administration, and pharmacokinetic monitoring.
  • Analysis of limitations in predicting nephrotoxicity using population pharmacokinetic models.

Related Experiment Videos

  • Investigation of probabilistic and deterministic modeling for aminoglycoside nephrotoxicity.

    • Main Results:

    • Altering dosing schedules (less frequent, higher doses) may reduce renal accumulation.
    • Co-administration with agents like polyaspartic acid or deferoxamine shows promise.
    • Probabilistic and deterministic modeling offer complementary predictive and control capabilities for nephrotoxicity.

    Conclusions:

    • Optimizing aminoglycoside dosing and employing protective agents can mitigate toxicity.
    • Advanced modeling techniques, particularly probabilistic and deterministic approaches, are crucial for predicting and managing aminoglycoside nephrotoxicity.
    • Integrating these models into clinical practice can enhance patient safety during aminoglycoside therapy.